1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        North America Latent TB Detection Market – By Test

1.3.2        North America Latent TB Detection Market – By End User

1.3.3        North America Latent TB Detection Market – By Country

2.           Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           North America Latent TB Detection Market – Market Landscape

4.1         Overview

4.2         North America PEST Analysis

5.           North America Latent TB Detection Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Growing Prevalence of Tuberculosis

5.1.2        Increasing Government Initiatives to Promote Tuberculosis Detection

5.2         Market Restraints

5.2.1        Presence of Multidrug Resistant Tuberculosis (MDR-TB)

5.3         Market Opportunities

5.3.1        Growth in Emerging Economies

5.4         Future Trends

5.4.1        Rising Advancements in Tuberculosis Diagnosis

5.5         Impact Analysis

6.           Latent TB Detection Market – North America Analysis

6.1         North America Latent TB Detection Market Revenue Forecast and Analysis

7.           North America Latent TB Detection Market Analysis – By Test

7.1         Overview

7.2         North America Latent TB Detection Market Share, by Test, 2019 and 2027 (%)

7.3         Tuberculin Skin Test (TST)

7.3.1        Overview

7.3.2        Tuberculin Skin Test (TST): Latent TB Detection Market– Revenue and Forecast to 2027 (US$ Million)

7.4         Interferon Gamma Released Assay (IGRA)

7.4.1        Overview

7.4.2        Interferon Gamma Released Assay (IGRA): Latent TB Detection Market– Revenue and Forecast to 2027 (US$ Million)

8.           North America Latent TB Detection Market Analysis – By End User

8.1         Overview

8.2         North America Latent TB Detection Market Share, by End User, 2019 and 2027 (%)

8.3         Hospitals

8.3.1        Overview

8.3.2        Hospitals: Latent TB Detection Market– Revenue and Forecast to 2027 (US$ Million)

8.4         Diagnostic Centers

8.4.1        Overview

8.4.2        Diagnostic Centers: Latent TB Detection Market– Revenue and Forecast to 2027 (US$ Million)

8.5         Laboratories

8.5.1        Overview

8.5.2        Laboratories: Latent TB Detection Market– Revenue and Forecast to 2027 (US$ Million)

8.6         Others

8.6.1        Overview

8.6.2        Others: Latent TB Detection Market– Revenue and Forecast to 2027 (US$ Million)

9.           North America Latent TB Detection Market Analysis and Forecasts To 2027 – Country Analysis

9.1         North America: Latent TB Detection Market

9.1.1        Overview

9.1.2        North America: Latent TB Detection Market, by Country, 2019 & 2027 (%)

9.1.3        US: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)

9.1.3.1          US: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)

9.1.3.2          US: Latent TB Detection Market, by Test – Revenue and Forecast to 2027 (USD Million)

9.1.3.3          US: Latent TB Detection Market, by End User – Revenue and Forecast to 2027 (USD Million)

9.1.4        Canada: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)

9.1.4.1          Canada: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)

9.1.4.2          Canada: Latent TB Detection Market, by Test – Revenue and Forecast to 2027 (USD Million)

9.1.4.3          Canada: Latent TB Detection Market, by End User – Revenue and Forecast to 2027 (USD Million)

9.1.5        Mexico: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)

9.1.5.1          Mexico: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)

9.1.5.2          Mexico: Latent TB Detection Market, by Test – Revenue and Forecast to 2027 (USD Million)

9.1.5.3          Mexico: Latent TB Detection Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.        Impact of COVID-19 Pandemic on North America Latent TB Detection Market

10.1      North America: Impact Assessment of COVID-19 Pandemic

11.        Industry Landscape

11.1      Overview

11.2      Organic Developments

11.2.1     Overview

11.3      Inorganic Developments

11.3.1     Overview

12.        Company Profiles

12.1      QIAGEN

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      bioMerieux SA

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      F. HOFFMANN-LA ROCHE LTD.

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      BD

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      Abbott

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6      Oxford Immunotec Ltd

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7      Lionex GmbH

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8      ARKRAY, Inc.

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Products and Services

12.8.4     Financial Overview

12.8.5     SWOT Analysis

12.8.6     Key Developments

12.9      Serum Institute of India Pvt. Ltd.

12.9.1     Key Facts

12.9.2     Business Description

12.9.3     Products and Services

12.9.4     Financial Overview

12.9.5     SWOT Analysis

12.9.6     Key Developments

13.        Appendix

13.1      About The Insight Partners

13.2      Glossary of Terms

Table 1.             North America Latent TB Detection Market – Revenue, and Forecast to 2027 (US$ Million)

Table 2.             US: Latent TB Detection Market, by Test – Revenue and Forecast to 2027 (USD Million)

Table 3.             US: Latent TB Detection Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 4.             Canada: Latent TB Detection Market, by Test – Revenue and Forecast to 2027 (USD Million)

Table 5.             Canada: Latent TB Detection Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 6.             Mexico: Latent TB Detection Market, by Test – Revenue and Forecast to 2027 (USD Million)

Table 7.             Mexico: Latent TB Detection Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 8.             Organic Developments Done By Companies

Table 9.             Inorganic Developments Done By Companies

Table 10.          Glossary of Terms

Figure 1.           North America Latent TB Detection Market Segmentation

Figure 2.           North America Latent TB Detection Market – By Country

Figure 3.           North America Latent TB Detection Market Overview

Figure 4.           Interferon Gamma Released Assay (IGRA) Segment Held Largest Share of North America Latent TB Detection Market

Figure 5.           US to Show Remarkable Growth During Forecast Period

Figure 6.           North America PEST Analysis

Figure 7.           North America Latent TB Detection Market Impact Analysis of Drivers and Restraint

Figure 8.           North America Latent TB Detection Market – Revenue Forecast and Analysis

Figure 9.           North America Latent TB Detection Market Share, by Test, 2019 and 2027 (%)

Figure 10.        North America Tuberculin Skin Test (TST): Latent TB Detection Market– Revenue and Forecast to 2027 (US$ Million)

Figure 11.        North America Interferon Gamma Released Assay (IGRA): Latent TB Detection Market– Revenue and Forecast to 2027 (US$ Million)

Figure 12.        North America Latent TB Detection Market Share, by End User, 2019 and 2027 (%)

Figure 13.        North America Hospitals: Latent TB Detection Market– Revenue and Forecast to 2027 (US$ Million)

Figure 14.        North America Diagnostic Centers: Latent TB Detection Market– Revenue and Forecast to 2027 (US$ Million)

Figure 15.        North America Laboratories: Latent TB Detection Market– Revenue and Forecast to 2027 (US$ Million)

Figure 16.        North America Others: Latent TB Detection Market– Revenue and Forecast to 2027 (US$ Million)

Figure 17.        North America: Latent TB Detection Market, by Key Country – Revenue (2019) (USD Million)

Figure 18.        North America: Latent TB Detection Market, by Country, 2019 & 2027 (%)

Figure 19.        US: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)

Figure 20.        Canada: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)

Figure 21.        Mexico: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)

Figure 22.        Impact of COVID-19 Pandemic in North American Country Markets